Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Coronary Events Drop in Italy After Smoking Ban
Link ID 3156
Title Coronary Events Drop in Italy After Smoking Ban
Url http://www.medscape.com/viewarticle/570052?src=rss
Description Another country has documented a drop in acute coronary events in the year following the introduction of a smoking ban in public places. The Italian researchers found an 11% drop in such events in Rome among those of working age. Heartwire
Category Articles > Cardiology
Keywords
Date Feb 12, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Preeclampsia May Increase Risk for End-Stage Renal Disease
  A study shows that the absolute risk for end-stage renal disease in women who have had preeclampsia is low but that preeclampsia is a marker of increased risk for subsequent end-stage renal disease. Medscape Medical News
Category:   Articles > Cardiology


2. More Evidence of Increased Fractures With Thiazolidinediones
  In a new case-control study, long-term use of either rosiglitazone or pioglitazone in patients with type 2 diabetes mellitus was associated with a 2-fold to 3-fold increased risk for fractures. Medscape Medical News
Category:   Articles > Cardiology


3. Coronary Calcification Thought to Predict Mortality in Hemodialysis Patients
  For people on hemodialysis, coronary artery calcification appears to be an independent predictor of mortality. Medscape Medical News
Category:   Articles > Cardiology


4. Introduction to the Hypertension Curriculum
  Drs. Thomas Giles, Suzanne Oparil, and Henry Black announce a new educational alliance with the American Society of Hypertension to improve prevention, detection, and management of hypertension.
American Society of Hypertension
Category:   Articles > Cardiology


5. Negative FIRE Trial Retains Flicker of Hope
  An exploratory phase 2 trial of a new small peptide compound, FX06, designed to cut reperfusion injury in STEMI patients, has failed to show a benefit on the primary end point. But the investigators are still planning a larger trial, convinced that the agent holds promise. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS